Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02935894 · ClinicalTrials.gov registry record · NA
Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat
A NA study of Stability & Variability of Lipid-derived Molecules in Sweat, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT02935894: Completed NA study of Stability & Variability of Lipid-derived Molecules in Sweat, sponsored by USDA, Western Human Nutrition Research Center.
NCT02935894 is a NA study of Stability & Variability of Lipid-derived Molecules in Sweat that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02935894, a NA study of Stability & Variability of Lipid-derived Molecules in Sweat, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see what the differences are in sweat (amount and small molecule content) collected from different sites of the body and by different methods of sweat stimulation. Additionally, the investigators want to know whether the amount and small molecule content of the sweat is the same in an individual over time, and the same across individuals at a given time. Finally, the investigators want to know how consumption of over-the-counter anti-inflammatory drugs such as ibuprofen will affect the inflammatory mediator content of sweat and how that compares to blood. This information will help to better understand the composition and behavior of sweat and assess its potential utility as a routine clinical tool in skin research.
Primary Outcome
Approximately 150 lipid mediators will be measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Assayed lipid mediators include oxygenated lipids, endocannabinoids and endocannabinoid-like molecules, and sphingolipids.
Conditions Studied
Interventions
- DRUG Ibuprofen
- DRUG Pilocarpine
- OTHER Physiological induction of sweating
Study Locations (1)
California
- Western Human Nutrition Research Center - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-11-28 |
| Est. Completion | 2017-06-08 |
| Phase | NA |
What the finished NCT02935894 record still lists
NCT02935894 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Stability & Variability of Lipid-derived Molecules in Sweat appearing as the primary indexed condition, and to 3 interventions - of which Ibuprofen is the first listed.
NCT02935894 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02935894 about?
NCT02935894 is a clinical study titled "Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat". The purpose of this study is to see what the differences are in sweat (amount and small molecule content) collected from different sites of the body and by different methods of sweat stimulation. Additionally, the investigators want to know whether the amount and small molecule content of the sweat ...
What is the current status of trial NCT02935894?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2016-11-28. Estimated completion is 2017-06-08.
What conditions does trial NCT02935894 study?
This clinical trial studies the following conditions: Stability & Variability of Lipid-derived Molecules in Sweat.
What interventions are being tested in trial NCT02935894?
The interventions under investigation include: Ibuprofen (DRUG), Pilocarpine (DRUG), Physiological induction of sweating (OTHER).
Who is sponsoring clinical trial NCT02935894?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02935894 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02935894's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy